As of 2025-07-13, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (407.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.19 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -6686.7%.
The range of the Relative Valuation is (335.16) - (469.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 13.6x | 11.6x |
| Forward P/E multiples | 9.7x - 14.2x | 12.0x |
| Fair Price | (335.16) - (469.91) | (407.71) |
| Upside | -5514.5% - -7691.4% | -6686.7% |
| Date | P/E |
| 2025-07-11 | -0.18 |
| 2025-07-10 | -0.18 |
| 2025-07-09 | -0.18 |
| 2025-07-08 | -0.17 |
| 2025-07-07 | -0.17 |
| 2025-07-03 | -0.17 |
| 2025-07-02 | -0.17 |
| 2025-07-01 | -0.17 |
| 2025-06-30 | -0.17 |
| 2025-06-27 | -0.16 |
| 2025-06-26 | -0.17 |
| 2025-06-25 | -0.16 |
| 2025-06-24 | -0.16 |
| 2025-06-23 | -0.16 |
| 2025-06-20 | -0.17 |
| 2025-06-18 | -0.16 |
| 2025-06-17 | -0.16 |
| 2025-06-16 | -0.17 |
| 2025-06-13 | -0.18 |
| 2025-06-12 | -0.18 |
| 2025-06-11 | -0.19 |
| 2025-06-10 | -0.19 |
| 2025-06-09 | -0.18 |
| 2025-06-06 | -0.19 |
| 2025-06-05 | -0.17 |
| 2025-06-04 | -0.19 |
| 2025-06-03 | -0.18 |
| 2025-06-02 | -0.18 |
| 2025-05-30 | -0.18 |
| 2025-05-29 | -0.18 |
| 2025-05-28 | -0.17 |
| 2025-05-27 | -0.19 |
| 2025-05-23 | -0.19 |
| 2025-05-22 | -0.19 |
| 2025-05-21 | -0.18 |
| 2025-05-20 | -0.19 |
| 2025-05-19 | -0.19 |
| 2025-05-16 | -0.17 |
| 2025-05-15 | -0.18 |
| 2025-05-14 | -0.20 |
| 2025-05-13 | -0.20 |
| 2025-05-12 | -0.21 |
| 2025-05-09 | -0.21 |
| 2025-05-08 | -0.21 |
| 2025-05-07 | -0.21 |
| 2025-05-06 | -0.20 |
| 2025-05-05 | -0.20 |
| 2025-05-02 | -0.20 |
| 2025-05-01 | -0.20 |
| 2025-04-30 | -0.21 |